Business
Axcan Pharma to present at the UBS Global Specialty Pharmaceuticals Conference
Axcan Pharma to present at the UBS Global Specialty Pharmaceuticals Conference.
About this update from Trailbreaker Resources Ltd
[{"type":"text","content":"\n\n\n\n\nTSX SYMBOL (Toronto Stock Exchange): AXP\nNASDAQ SYMBOL (NASDAQ National Market): AXCA\n\nMONT SAINT-HILAIRE, April 18 /CNW Telbec/ - Axcan Pharma Inc. (\"Axcan\" or\nthe \"Company\") today announced that on Tuesday, April 25th, 2006, President\nand Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will present an\noverview of the Company at the UBS Global Specialty Pharmaceuticals Conference\nto be held in New York, NY. This presentation will take place at 1:30 p.m.\n(Eastern time).\nA live webcast of Axcan's presentation will also be accessible via the\nCompany's website at www.axcan.com.\n\nAxcan is a leading specialty pharmaceutical company involved in the field\nof gastroenterology. The Company markets a broad line of prescription products\nsold for the treatment of symptoms in a number of gastrointestinal diseases\nand disorders such as inflammatory bowel disease, irritable bowel syndrome,\ncholestatic liver diseases and complications related to cystic fibrosis.\nAxcan's products are marketed by its own sales force in North America and\nEurope. Its common shares are listed on the Toronto Stock Exchange under the\nsymbol \"AXP\" and on the NASDAQ National Market under the symbol \"AXCA\".\n\n\n","length":1282,"tagName":"div"}]